Polar Asset Management Partners’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Polar Asset Management Partners’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-255,665	Closed	-$8.64M	–	1552
2021 Q2	$8.64M	Buy	+255,665	New	+$6.51M	0.09%	254

Polar Asset Management Partners's CNST Position: Q3 2021 in Review

Polar Asset Management Partners sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 255,665 shares — an estimated $8.64M sold.

Polar Asset Management Partners first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $8.64M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Polar Asset Management Partners reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Polar Asset Management Partners sold 255,665 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $8.64M.
Polar Asset Management Partners first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Polar Asset Management Partners's Constellation Pharmaceuticals, Inc. position peaked at $8.64M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.